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New onset refractory status epilepticus (NORSE) is a new entity in medical literature. It has different infectious and noninfectious
etiologies showing a devastating impact onto the clinical outcome of patients. Therapy with anaesthetic and antiepileptic agents
often fails to improve the condition, unless the primary cause is rectified. Here is presented the case of a young female with a history
of depressionwho after a recent bereavement came to the EmergencyDepartment of Aga KhanUniversityHospital with complaints
of drowsiness that lasted for few hours. Though she had no history of organophosphate poisoning, her physical examination and
further investigations were suggestive of the diagnosis. During her hospital stay, she developed refractory status epilepticus. Her
seizures did not respond to standard antiepileptic and intravenous anesthetic agents and subsided only after intravenous infusion
of atropine for a few days. Organophosphate poisoning is a very common presentation in the developing world and the associated
status epilepticus poses a devastating problem for emergency physicians. In patients with suspected organophosphate poisoning
with favoring clinical exam findings, the continuation of atropine intravenous infusion can be a safe option to abate seizures.
1. Introduction
Organophosphates are some of the most common agents of
poisoning that account for approximately 60% of all poison-
ing cases in Pakistan [1]. It is considered that the primary
mechanism of action of these compounds is the irreversible
inhibition of acetylcholinesterase (AChE), which results in
the accumulation of acetylcholine at the nerve synapses and
the stimulation of seizure activity (convulsions). This, when
coupled with the existence of excitatory neurotransmitters,
activates theNMDAreceptors in the brain, eventually leading
to status epilepticus [2].
New onset refractory status epilepticus (NORSE) is a
relatively new addition in the medical literature and is used
to describe a condition where previously healthy adults now
present with de novo refractory status epilepticus [3]. An
infectious insult, especially viral encephalitis, is regarded as a
harbinger for its onset but evidence is still lacking to confirm
this [4].
In organophosphate poisoning, status epilepticus is asso-
ciated with different chemical warfare agents like sarin,
sobun, and tabun. The toxicity of these agents is focused
on the central and peripheral nervous systems [5]. Here is
reported the case of a patient presenting with NORSE and
organophosphate poisoningwhichwas suspected on the basis
of clinical features and low serum acetylcholinesterase levels.
2. Case Presentation
A 27-year-old woman, recently bereaved due to the death
of her 6-month-old daughter, came to the emergency with
the sudden onset of drowsiness that lasted for 4 hours.
She had no history of poisoning or drug overdose. On her
physical examination, a clear observation of pinpoint pupils,
bradycardia, bronchorrhea, and the drooling of saliva raised
strong suspicions of organophosphate poisoning, which is
usually one of the most common types of poisoning in
developing countries.
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Her treatment started with the administration of intra-
venous atropine and pralidoxime based on her physical
examination findings. A few hours later she developed
seizures for which she was administered intravenous benzo-
diazepine. Despite treatment, the seizures continued. She was
given multiple antiepileptic drugs, none of which controlled
the seizures. She was then intubated due to her condition
of having refractory status epilepticus and the electrolytes
were normal. She was put under 24-hour EEG monitor-
ing, which showed continuous seizure activity. CSF studies
along with brain imaging to point towards any infectious
or ischemic etiology for her condition were found to be
negative. Meanwhile she remained on intravenous atropine
and pralidoxime. Her seizures were controlled after 3 days of
treatment. When intravenous administration of atropine and
pralidoxime was stopped, the seizures recommenced within
a few hours. Her intravenous anesthetic dose was increased
and she was put on a combination of five antiepileptic
medications. Based on her examination findings and clinical
parameters, the treatment combo of intravenous atropine and
pralidoxime was restarted. She continued to have seizures
for 6 days. Finally her seizures were controlled after 10 days
via application of intensive intravenous anesthetic agents,
antiepileptic medications, and atropine infusion. The appli-
cation of antiepilepticmedications, atropine, and intravenous
anesthetic agents was gradually tapered. The patient was
extubated after a few days and remained well afterwards. She
was discharged home on prescription of oral levetiracetam
and phenytoin with neurology follow-ups.
3. Discussion
This case highlights a very serious and lethal manifestation
of organophosphate poisoning, which was NORSE caused
by a possible household agent. We were unable to identify
the substance the patient had ingested, and she had no
history of fumigation within her house. Data from the
National Poison Control Centre, Karachi, Pakistan, reported
1999 cases of organophosphate poisoning with CNS mani-
festations including only altered consciousness and seizures,
but not NORSE [1]. Review articles on neurotoxic effect
of organophosphate poisoning also failed to mention such
a severe CNS presentation [6]. This case emphasizes the
need for having stringent regulations regarding the use
of pesticides in Pakistan. According to WHO, extremely
hazardous (class 1a) and highly hazardous (class 1b) pesticides
[7] should not be used in households; they should be available
only to licensed personnel and should bear a label of either
“poison” or “toxic” to indicate a high degree of hazard. Failure
in complying with these regulations leads to higher mortality
in developing countries. Ban on sale of these products may
improve poisoning related deaths in developing country like
Pakistan [8].
This case also highlights the importance of recognizing
toxidromes to reach a diagnosis, as most of the time the
history of toxic ingestion is not available. The patient was
in cholinergic crisis, as recognized solely on clinical man-
ifestation. This cholinergic crisis could also have been due
to some plant poisoning through alkaloid compounds such
as solanine that inhibit cholinesterase enzyme similar to an
organophosphate compound [9].The specificmanagement of
a severe cholinergic crisis due to the cholinesterase inhibition
is the intravenous administration of atropine/pralidoxime as
antidote and supportive care with fluids and electrolytes. In
this particular case, the patient was managed on the basis of
clinical findings alone, and later on diagnosis was confirmed
through serum acetylcholinesterase levels. As testing for RBC
cholinesterase levels is not available in Aga Khan University
Hospital, serum cholinesterase levels were considered in
diagnosis. This case also suggests that poisonings should
always be considered in differential diagnosis of any new
symptomatology, because specific treatment would affect the
outcome as described in this case. The risk of poisoning/self-
harm was suspected as she had gone through a recent
bereavement and as per her husband she had been depressed
after the death of her child who died as a result of an accident
and she was on antidepressants. She was a housewife and was
living with 3 children. Also she has both clinical features and
low cholinesterase levels.
Organophosphate is the most common cause of poison-
ing in Pakistan because it is cheap and easily available over
the counter and has no regulatory control [10].
We had been doing serial blood cholinesterase levels as it
is the test that is available in Pakistan and in our institution.
The RBC cholinesterase level although more sensitive is not
available in our institution. Both atropine and pralidoxime
infusions are continued until the resolution of symptoms
and signs. The atropine infusion was continued at 2mg per
hour. The patient was followed clinically both for resolution
of cholinergic symptoms and for cholinesterase level that
showed a rise. Serial cholinesterase level not only has a good
sensitivity but also has a prognostic value in terms of outcome
in organophosphate poisoning [11, 12].
The average duration of NORSE as reported by Costello
et al. is believed to be 36 days (6–68 days) [13], and a case
from Verma et al. had the duration of 12 days with herpes
simplex encephalitis as the putative agent for the event. The
case discussed in this paper/report had a probable toxic insult
which lasted for 10 days after the continuation of the atropine
infusion. Also, patients who were presented in the past with
NORSE had some common clinical features which include
female sex, young age at presentation, no prior history of any
neurological disorder or seizures, neuroimaging, and CSF
abnormalities, all of which were consistent in our patient.The
association of the status epilepticus with chemical warfare
agents is shown in the literature. The above case presentation
points towards thinking of whether any substancewas used in
the household or there was any other cause for these clinical
features and low serum acetyl cholinesterase levels.
In the treatment of the patient discussed here, multiple
antiepileptic drugs were tried which were unsuccessful in
controlling seizures. One recent study reported the efficacy
of sec-butyl-propylacetamide (SPD), a one-carbon homolog
of valnoctamide (VCD), which is a central nervous system-
(CNS-) active amide derivative of valproic acid (VPA), to be
effective in diazepam resistant cases of status epilepticus in
organophosphate poisoning cases. This drug is currently in
phase II of clinical trials.
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4. Why Should an Emergency Physician Be
Aware of It?
New onset refractory status epilepticus in patients with clin-
ical features suggesting organophosphate poisoning is a rare
entity. In patients with suspected organophosphate poisoning
with favoring clinical exam findings, the continuation of
atropine intravenous infusion can be a safe option to abate
seizures.
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